Menu

Blog Posts

Senate Committee Doubles Down on PBM Bill with 340B Spread Pricing Language

William Newton Washington Correspondent Views
Sen. Ron Wyden (D-Ore.), chairman of the Senate Finance Committee, announced a Dec. 5 hearing on prescription drug shortages that will include testimony from two witnesses who have published research on the 340B program.
Members of the Senate Finance Committee yesterday reiterated support for a pharmacy benefit manager (PBM) transparency bill with 340B spread [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Indiana Health Care Leaders Call for 340B Transparency in Op-Ed

William Newton Washington Correspondent Views
Two Indiana Health Center leaders—TJ Warren (left) and Ben Harvey (right)—called for greater 340B program transparency in a recent op-ed.
The CEOs of an Indiana-based community health center and a primary care association recently wrote an op-ed that called for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

GlaxoSmithKline Posts Refund Notice on HRSA Website

Rich Daly Editor in Chief Views
GlaxoSmithKline wordmark and GSK logo on a building
Drugmaker GlaxoSmithKline owes refunds to 340B providers for eight of its products, a recent HRSA notice said.
GlaxoSmithKline owes refunds to 340B providers, according to a notice posted on the Health Resources and Services Administration’s Office of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Genesis Ruling Could Expand 340B-Eligible Prescriptions, Say Some Attorneys

Rich Daly Editor in Chief Views
Kyle Vasquez, an attorney for Polsinelli, said the Genesis ruling was "limited in reach" but could create obstacles for other HRSA enforcement activity.
A recent ruling by a federal district judge in South Carolina potentially could expand 340B-eligible prescriptions, say some provider advisers. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Hospitals Urge CMS to Reconsider Future Cuts in 340B Lump Sum Final Rule

Rich Daly Editor in Chief Views
Tom Kraus, a vice president of the American Society of Health-System Pharmacists, said he was "deeply concerned" with future cuts in CMS' 340B lump sum final rule.
Hospital advocates praised the recent Medicare final rule implementing a $9 billion lump sum payment to 340B hospitals but worried [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Unlocking Greater 340B Savings

Sponsored Content Views
How to capture claims and savings that are often missed

SPONSORED CONTENT

The 340B program serves as a lifeline for many communities, allowing them to provide critical services to vulnerable, underserved patients. But unfortunately, the industry faces a spectrum of challenges, from mounting drug manufacturer restrictions to incomplete referral claims capture, which hinder a covered entity’s ability to optimize their 340B program.

To help

…
Read More »

Lilly Reinstates Tighter 340B Contract Pharmacy Restrictions

William Newton Washington Correspondent Views
Lilly
Drugmaker Eli Lilly's recently announced 340B contract pharmacy policy will not apply to Arkansas-based contract pharmacies.
Pharmaceutical giant Eli Lilly this week announced it would reinstate tighter 340B contract pharmacy restrictions for all covered entity types. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

HRSA, Hospital Settle Lawsuit Over Termination from 340B

Tom Mirga Editor at Large Views
The hospital Insight Chicago and federal regulators have agreed to dismiss a case before a federal district court over the hospital's 340B eligibility.
A federal district judge in Illinois has dismissed a Chicago hospital’s apparently successful lawsuit challenging its termination from the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Senate Finance Committee Republicans Oppose CMS Plan to Redefine Medicaid Best Price

Tom Mirga Editor at Large Views
Senate Finance Committee
A group of Republicans on the Senate Finance Committee have called on CMS to withdraw its plan to rewrite the definition of Medicaid best price.
A group of Senate Republicans recently urged federal regulators to withdraw a plan to change the definition of a drug’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report